Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes
Open accessThe DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Since the 2007 Diabetes Surgery Summit in Rome, Italy, and the subsequent publishing of the world’s first guidelines for the surgical treatment of type 2 diabetes (T2D), much new evidence regarding the efficacy and safety of metabolic surgery has emerged. Additional observational cohort studies support the superior effects of surgery over medical treatment with respect to glycemic control, weight loss, and even reduction in mortality and microvascular complications associated with T2D. Furthermore, new safety data suggest that the perioperative morbidity and mortality of metabolic surgery (5% and 0.3%, respectively) are now similar to that of common low-risk procedures, such as cholecystectomy and hysterectomy. The largest advance, however, has been the completion of 11 randomized controlled trials from around the globe that compare surgery with medical treatment of T2D. These studies with follow-up duration of 1–5 years involve nearly 800 patients without surgical mortality and with major complication rates of less than 5% and a reoperation rate of 8%. All but 1 of the 11 randomized controlled trials have shown the superiority of surgery over medical management at achieving remission or glycemic improvement. Surgery was also superior to medical treatment with respect to improving cardiovascular risk factors, such as weight loss and dyslipidemia, while reducing medication burden. This new efficacy and safety evidence should help guide physicians across the globe to the appropriate use of surgery as an effective treatment for patients suffering from T2D and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term results of MBS consistently demonstrate safety and efficacy.”
From 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
The cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Self-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Self-citationGastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901 · cited 4×
“In the medical control group, greater than 5% weight gain (16%) was among the most common adverse event (31).”
BackgroundInfluentialSelf-citationBariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Self-citationBariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656 · cited 1×
“002), despite a greater prevalence of smoking and higher baseline weights and blood pressures in the surgical cohort (16).”
BackgroundBariatric Surgery Worldwide 2013
Angrisani, L., Santonicola, A., Iovino, P., Formisano, G., Buchwald, H., & Scopinaro, N. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1657-z · Cited by 1,491
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 5×
“Ikramuddin et al. (34) uniquely used a composite primary end point based on the ADA 2009 guidelines defined as the success rate of reaching an HbA1c,7.0%, LDL cholesterol ,100 mg/dL, and systolic blood pressure ,130 mmHg.”
BackgroundInfluentialPerioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220 · cited 9×
“(33) had the longest follow-up (5 years) and showed superior and durable weight loss and glycemic control (remission) with both RYGB and BPD compared with medical therapy (Fig.”
BackgroundResultInfluentialSelf-citationSjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 1×
“In the SOS study, for patients with T2D, surgery was associated with a 50% reduction in microvascular complications (29).”
MethodCourcoulas, A. P. (2013) · JAMA · doi:10.1001/jama.2013.280928 · Cited by 799
Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA · doi:10.1001/jama.2013.5835 · Cited by 735
Self-citationTrends in mortality in bariatric surgery: a systematic review and meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., & Sledge, I. (2007) · Surgery · doi:10.1016/j.surg.2007.07.018 · Cited by 685
Health benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674 · cited 3×
“an insufficient time to demonstrate a mortality benefit (24,25).”
BackgroundBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552 · cited 1×
“or reduced development of nephropathy after bariatric surgery has been reported (27,28).”
BackgroundSelf-citationSystematic review of sleeve gastrectomy as staging and primary bariatric procedure
Brethauer, S. A., Hammel, J. P., & Schauer, P. R. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.05.011 · Cited by 536
Self-citationNIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
(1991) · PubMed · Cited by 496
Bariatric surgery: an IDF statement for obese Type 2 diabetes
Dixon, J. B., Zimmet, P., Alberti, K. G., Rubino, F., & on behalf of the International Diabetes Federation Taskforce on Epidemiology and Prevention (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03306.x · Cited by 494
Association Between Bariatric Surgery and Long-term Survival
Arterburn, D. E., Olsen, M. K., Smith, V. A., Livingston, E. H., Van Scoyoc, L., Yancy, W. S., Eid, G., Weidenbacher, H., & Maciejewski, M. L. (2015) · JAMA · doi:10.1001/jama.2014.16968 · Cited by 479 · cited 1×
“(25) involved mostly higher-risk, male veterans, who were later determined after longer followup to demonstrate a 42% reduction in mortality at 10 years with bariatric surgery as compared with medical therapy (26).”
BackgroundLong-term Outcomes of Laparoscopic Adjustable Gastric Banding
Himpens, J. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.45 · Cited by 403
Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action
Rubino, F., Schauer, P. R., Kaplan, L. M., & Cummings, D. E. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.051308.105148 · Cited by 381 · cited 1×
“data supporting metabolic surgery but light in terms of randomized controlled trials (RCTs) (7).”
BackgroundSelf-citationCourcoulas, A. P., Belle, S. H., Neiberg, R. H., Pierson, S. K., Eagleton, J. K., Kalarchian, M. A., DeLany, J. P., Lang, W., & Jakicic, J. M. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.1534 · Cited by 376 · cited 1×
“Results were mixed in terms of improvements in systolic and diastolic blood pressure (34,39) and LDL cholesterol (33) after surgery compared with medical treatment, but many studies did show a corresponding reduction”
ResultMechanisms of diabetes improvement following bariatric/metabolic surgery
Batterham, R. L., & Cummings, D. E. (2016) · Diabetes Care · doi:10.2337/dc16-0145 · Cited by 376 · cited 2×
“Other contributing mechanisms of diabetes control after surgery are also addressed in the articles from Batterham and Cummings (1) and Holst et al. (2), which appear in this issue of Diabetes Care.”
BackgroundMicronutrient deficiencies after bariatric surgery
Shankar, P., Boylan, M., & Sriram, K. (2010) · Nutrition · doi:10.1016/j.nut.2009.12.003 · Cited by 355 · cited 6×
“The procedures along with frequency of use include sleeve gastrectomy (SG) (49%), Roux-en-Y gastric bypass (RYGB) (43%), laparoscopic adjustable gastric banding (LAGB) (6%), and biliopancreatic diversion with duodenal switch (BPD+DS) (2”
BackgroundInfluentialBariatric surgery and cardiovascular outcomes: a systematic review
Vest, A. R., Heneghan, H. M., Agarwal, S., Schauer, P. R., & Young, J. B. (2012) · Heart · doi:10.1136/heartjnl-2012-301778 · Cited by 336 · cited 1×
“A recent systematic review of longterm cardiovascular risk factor reduction after bariatric surgery involved 73 studies and 19,543 patients (22).”
BackgroundSelf-citationRubino, F., Kaplan, L. M., Schauer, P. R., & Cummings, D. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181be34e7 · Cited by 325
Self-citationCummings, D. E., Arterburn, D. E., Westbrook, E. O., Kuzma, J. N., Stewart, S. D., Chan, C. P., Bock, S. N., Landers, J. T., Kratz, M., Foster-Schubert, K. E., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3903-x · Cited by 314
Halperin, F., Ding, S.-A., Simonson, D. C., Panosian, J., Goebel-Fabbri, A., Wewalka, M., Hamdy, O., Abrahamson, M., Clancy, K., Foster, K., et al. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.514 · Cited by 245
Surgical vs Medical Treatments for Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Courcoulas, A. P., Goodpaster, B. H., Eagleton, J. K., Belle, S. H., Kalarchian, M. A., Lang, W., Toledo, F. G. S., & Jakicic, J. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.467 · Cited by 225 · cited 10×
“The 2011 International Diabetes Federation (IDF) position statement on metabolic surgery stated that metabolic surgery 1) should be an accepted option in people who have T2D and BMI $35 kg/m2 and 2) should also be considered as an alternative treatment option in people with T2D and BMI 30–35 kg/m2, or BMI 27.5–32.5 kg…”
MethodInfluentialVitamin and Trace Mineral Levels after Laparoscopic Gastric Bypass
Madan, A., Orth, W., Tichansky, D., & Ternovits, C. (2006) · Obesity Surgery · doi:10.1381/096089206776945057 · Cited by 216 · cited 1×
“In one study, preoperative deficiencies were common: vitamin A (11%), vitamin B12 (13%), vitamin D (40%), zinc (30%), iron (16%), ferritin (9%), selenium (58%), and folate (6%) (52).”
BackgroundIkramuddin, S., Billington, C. J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Jeffery, R. W., Chong, K., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00089-3 · Cited by 207 · cited 1×
“Among the RCTs, the most common predictors of diabetes remission included duration of diabetes, weight loss, requirement for insulin, and disease status (HbA1c) (31,33,35).”
BackgroundSelf-citationLiang, Z., Wu, Q., Chen, B., Yu, P., Zhao, H., & Ouyang, X. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.005 · Cited by 206 · cited 1×
“Demographics in terms of age, sex, and ethnic background were similar, although 2 studies (34,36) included a”
ResultRoles of the Gut in Glucose Homeostasis
Holst, J. J., Gribble, F., Horowitz, M., & Rayner, C. K. (2016) · Diabetes Care · doi:10.2337/dc16-0351 · Cited by 205 · cited 2×
“Few crossovers (2) from the medical treatment group to surgery have been reported thus far”
BackgroundHow safe is metabolic/diabetes surgery?
Aminian, A., Brethauer, S. A., Kirwan, J. P., Kashyap, S. R., Burguera, B., & Schauer, P. R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12405 · Cited by 193
Self-citationObesity, bariatric surgery, and iron deficiency: True, true, true and related
Love, A. L., & Billett, H. H. (2008) · American Journal of Hematology · doi:10.1002/ajh.21106 · Cited by 166 · cited 1×
“ciency anemia in premenopausal patients (53).”
Possible risk factors for increased suicide following bariatric surgery
Mitchell, J. E., Crosby, R., de Zwaan, M., Engel, S., Roerig, J., Steffen, K., Gordon, K. H., Karr, T., Lavender, J., & Wonderlich, S. (2013) · Obesity · doi:10.1002/oby.20066 · Cited by 162
Survival Among High-Risk Patients After Bariatric Surgery
Maciejewski, M. L. (2011) · JAMA · doi:10.1001/jama.2011.817 · Cited by 160 · cited 2×
“an insufficient time to demonstrate a mortality benefit (24,25).”
BackgroundEffect of Gastric Bypass Surgery on Kidney Stone Disease
Matlaga, B. R., Shore, A. D., Magnuson, T., Clark, J. M., Johns, R., & Makary, M. A. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.02.029 · Cited by 150
Manning, S., Pucci, A. B. F., Carter, N. C., Elkalaawy, M., Querci, G., Magno, S., Tamberi, A., Finer, N., Fiennes, A., Hashemi, M., et al. (2014) · Surgical Endoscopy · doi:10.1007/s00464-014-3829-7 · Cited by 149
Effects of Bilio-Pancreatic Diversion on Diabetic Complications
Iaconelli, A., Panunzi, S., Gaetano, A. D., Manco, M., Guidone, C., Leccesi, L., Gniuli, D., Nanni, G., Castagneto, M., Ghirlanda, G., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1761 · Cited by 149
Self-citationWentworth, J. M., Playfair, J., Laurie, C., Ritchie, M. E., Brown, W. A., Burton, P., Shaw, J. E., & O'Brien, P. E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70066-x · Cited by 144
Ding, S.-A., Simonson, D. C., Wewalka, M., Halperin, F., Foster, K., GOEBEL-FABBRI, A. E., Hamdy, O., Clancy, K. A., Lautz, D. B., Vernon, A. H., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1443 · Cited by 125 · cited 2×
“(42), all others (10 of 11) showed that surgery was superior to medical treatment with respect to reaching the primary end point (P, 0.”
BackgroundParikh, M., Chung, M., Sheth, S., McMacken, M., Zahra, T., Saunders, J. K., Ude-Welcome, A., Dunn, V., Ogedegbe, G., Schmidt, A. M., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000919 · Cited by 123
Substance use after bariatric surgery: A review
Li, L., & Wu, L.-T. T. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.009 · Cited by 101
Surgical Management of Obesity and the Relationship to Cardiovascular Disease
Vest, A. R., Heneghan, H., Schauer, P. R., & Young, J. B. (2013) · Circulation · doi:10.1161/circulationaha.112.103275 · Cited by 72 · cited 1×
“cohort-matched, nonrandomized studies comparing bariatric surgery with nonsurgical control subjects have been recently reviewed, and they broadly support a cardiovascular event and all-cause mortality benefit conferred by bariatric surgery (23).”
Self-citationA complication of Roux-en-Y gastric bypass: intestinal obstruction
Rogula, T. G., Yenumula, P. R., & Schauer, P. R. (2007) · Surgical Endoscopy · doi:10.1007/s00464-007-9535-y · Cited by 70 · cited 1×
“5%–2%) and marginal ulcers (1%–5%) (48,49).”
Self-citationSelective Nonoperative Management of Leaks After Gastric Bypass
Thodiyil, P. A., Yenumula, P. R., Rogula, T. G., Górecki, P., Fahoum, B. H., GOURASH, W. F., Ramanathan, R. C., Mattar, S. G., Shinde, D., Arena, V. C., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31818584aa · Cited by 67 · cited 1×
“5%–2%) and marginal ulcers (1%–5%) (48,49).”
Self-citationScibora, L. M. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12363 · Cited by 66
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Adams, T. D., Arterburn, D. E., Nathan, D. M., & Eckel, R. H. (2016) · Diabetes Care · doi:10.2337/dc16-0157 · Cited by 66 · cited 2×
“(12) in this special collection in Diabetes Care will address the effect of metabolic surgery on hard clinical outcomes, including long-term mortality, cardiovascular events, and microvascular disease (retinopathy, nephropathy, and others).”
BackgroundMicronutrient Deficiencies After Laparoscopic Gastric Bypass: Recommendations
Gong, K., Gagner, M., Pomp, A., Almahmeed, T., & Bardaro, S. J. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9577-9 · Cited by 52 · cited 1×
“deficits can be prevented or corrected (55).”
Bariatric procedures: an update on techniques, outcomes and complications
Baptista, V., & Wassef, W. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283651af2 · Cited by 48 · cited 1×
“cations is mandatory following these procedures (57).”
Thornton, C. M., Rozen, W. M., So, D., Kaplan, E. D., & Wilkinson, S. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9672-y · Cited by 33 · cited 1×
“perforations are well documented and occur in about 20% of patients (50).”
BackgroundThe effects of bariatric surgery on bone and nephrolithiasis
Sakhaee, K., POINDEXTER, J. R., & Aguirre, C. (2015) · Bone · doi:10.1016/j.bone.2015.12.001 · Cited by 32 · cited 1×
“The underlying mechanisms of kidney stone formation following bariatric surgery are complex and include hyperoxaluria, hypocitraturia, and abnormally acid urine (59).”
BackgroundEffect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes
Singh, R. P., Gans, R., Kashyap, S. R., Bedi, R., Wolski, K., Brethauer, S. A., Nissen, S. E., Bhatt, D. L., & Schauer, P. (2015) · Diabetes Care · doi:10.2337/dc14-2035 · Cited by 29 · cited 1×
“5%, of patients within all treatment groups had no change in retinopathy scoring (44).”
BackgroundSelf-citationReporting weight change: standardized reporting accounting for baseline weight
Belle, S. H., Berk, P. D., Courcoulas, A. P., Engel, S. G., Flum, D. R., GOURASH, W. F., Horlick, M., Hsu, J. Y., Khandelwal, S., Mitchell, J. E., et al. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.11.006 · Cited by 25
Self-citationCorrelation between the Beck Depression Inventory and bariatric surgical procedures
Ayloo, S. M., Thompson, K. J., Choudhury, N., & Sheriffdeen, R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.005 · Cited by 24 · cited 1×
“Paradoxically, although bariatric surgery has been shown to significantly decrease depression (61),”
BackgroundRecent National Trends In The Surgical Treatment of Obesity: Sleeve Gastrectomy Dominates
Khorgami, Z., Andalib, A., Corcelles, R., Aminian, A., Brethauer, S. A., & Schauer, P. R. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.012 · Cited by 22 · cited 2×
“adjustable gastric banding (LAGB) (6%), and biliopancreatic diversion with duodenal switch (BPD+DS) (2%) (4) (Fig.”
BackgroundSelf-citation
Cited by
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., De Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.013 · Cited by 985
“[15] Schauer PR, Mingrone G, Ikramuddin S, Wolfe B.”
BackgroundKhan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
“…the potential for remission of CKM conditions (eg, restoration of insulin sensitivity to ideal glycemic status, normalization of blood pressure), 10 even back to stage 0 with targeted preventive interventions (eg, health behavior interventions to promote ideal cardiovascular health [CVH]).”
BackgroundEisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06332-1 · Cited by 768
Treatment of Obesity: Weight Loss and Bariatric Surgery
Wolfe, B. M., Kvach, E., & Eckel, R. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.307591 · Cited by 648
“It has, therefore, been demonstrated that both weight loss and RYGB contribute to the superior remission of diabetes mellitus after gastric bypass compared with LABG.70 Recurrence of diabetes mellitus after induction of remission may occur in as many as 58% of patients 15 years after bariatric surgery, predominantly i…”
Self-citation
Metadata
- Authors
- Schauer, P. R., Mingrone, G., Ikramuddin, S., & Wolfe, B.
- Affiliations
- Cleveland Clinic (US)
- Catholic University, Rome, Italy
- University of Minnesota (US)
- Oregon Health & Science University (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-05-13
- Volume
- 39
- Issue
- 6
- Pages
- 902-911
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5864131
- OpenAlex
- W2404591441
- Cited by
- 215
- References
- 66
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 25 · 2020: 24 · 2019: 25 · 2018: 29 · 2017: 27 · 2016: 9
- FWCI
- 33.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- metabolic surgery, type 2 diabetes, diabetes remission, glycemic control, weight loss, obesity, perioperative morbidity, surgical safety, cardiovascular risk factors, dyslipidemia, medication burden, randomized controlled trials, surgical versus medical treatment
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Consensus Statements as Topic, Diabetes Mellitus, Type 2, Female, Humans, Obesity, Remission Induction, Risk Factors, Cohort Studies, Weight Loss, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.